does semaglutide damage kidneys significant 24% reduction in kidney disease progression and death related to kidney and cardiovascular causes in those treated with compared to a placebo Ozempic Approved for Diabetic Kidney

Participate in a monthly program designed to support consistent, supervised progress

Doctors provide advice about changes in cholesterol and explain how a healthier metabolism helps blood vessels work better

Serum testosterone and IL-1 levels decreased significantly, whereas estradiol and progestin levels increased significantly

The SHAPE study, analyzing real-world prescribing data, found: At 3 months: tirzepatide users lost 5.9% of body weight versus 3.6% for semaglutide At 6 months: 10.1% versus 5.8% At 12 months: 15.3% versus 8.3% These are averages from actual patients, not trial participants

To learn more, contact our team today!